BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Biotech Bay

  XOMA (US) LLC to Webcast Analyst and Investor Event ‘Interleukin-1 Blockers: Unlocking Their Potential in Diabetes and Beyond’ On September 25

  September 22, 2008

   · 

  1 min read
• Business

  ACORN Contract Research Organization Appoints Tara Webb as Senior Director of CRO Business Development

  September 22, 2008

   · 

  3 min read
• Biotech Beach

  Asphelia Pharmaceuticals Announces Fall 2008 Conference Schedule

  September 22, 2008

   · 

  1 min read
• Pharm Country

  Integra LifeSciences Holdings Corporation Announces $700,000 In-Kind Donation of Medical Devices to Boston University School of Medicine

  September 22, 2008

   · 

  1 min read
• Drug Development

  PAION Announces Phase I Study With Sedative/Anaesthetic CNS 7056 Progressed to Midazolam Comparison

  September 22, 2008

   · 

  1 min read
• Genetown

  Spherics, Inc. Presented Three Key Technologies at the 35th Annual Meeting of Controlled Release Society

  September 22, 2008

   · 

  1 min read
• FDA

  Mylan Inc. Receives FDA Approval for Generic Version of Parkinson’s Treatment Parcopa(R) ODT Represents Another Mylan First-to-Market Opportunity

  September 22, 2008

   · 

  1 min read
• Policy

  FDA Meeting Provides Green Light for Cell Therapeutics, Inc. Submission of Supplemental Filing for Zevalin(R) Label Expansion Supplemental Biologics License Application (sBLA) on track for Q4 Submission

  September 22, 2008

   · 

  6 min read
• Lone Star Bio

  CSMG Technologies Updates Shareholders on Key Developments, Including Recent U.S. FDA and European CE Mark Clearance for Live Tissue Connect Surgical Device, Targets Initial Sales

  September 22, 2008

   · 

  1 min read
• Drug Development

  RegeneRx Biopharmaceuticals, Inc. Enrolls First Subject in RGN-352 Phase IB Clinical Trial

  September 22, 2008

   · 

  1 min read